SCM
Soleus Capital Management Portfolio holdings
AUM
$2.47B
1-Year Est. Return
115.63%
This Fund
S&P 500
1 Year Est. Return
+115.63%
AUM
$2.47B
AUM Growth
+$112M
(+4.7%)
Holding
119
Top Buys
| 1 | +$104M | |
| 2 | +$63.4M | |
| 3 | +$63.3M | |
| 4 |
Krystal Biotech
KRYS
|
+$56.4M |
| 5 |
Progyny
PGNY
|
+$44.3M |
Top Sells
| 1 | +$80.6M | |
| 2 | +$74.2M | |
| 3 | +$57.1M | |
| 4 |
BioMarin Pharmaceuticals
BMRN
|
+$39M |
| 5 |
GSK
GSK
|
+$31.3M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Krystal Biotech
KRYS
$9.07B
| $298M | 12.06% |
1,153,087
+212,028
|
|
||
2
Celcuity
CELC
$4.51B
| $147M | 5.94% |
1,284,378
-523,880
|
|
||
3
TG Therapeutics
TGTX
$6.21B
| $134M | 5.42% |
4,029,319
+890,007
|
|
||
4
Insulet
PODD
$10.1B
| $118M | 4.78% |
562,500
+412,500
|
|
||
5
NovoCure
NVCR
$2.08B
| $114M | 4.63% |
10,492,391
+1,961,726
|
|
||
6
United Therapeutics
UTHR
$23.2B
| $111M | 4.5% |
187,187
+127,187
|
|
||
7
Praxis Precision Medicines
PRAX
$7.38B
| $106M | 4.31% |
330,517
-32,449
|
|
||
8
Vericel Corp
VCEL
$1.82B
| $82M | 3.32% |
2,549,079
+1,785,079
|
|
||
9
Alkermes
ALKS
$7.23B
| $69.7M | 2.82% |
1,970,864
+648,500
|
|
||
10
ANI Pharmaceuticals
ANIP
$1.8B
| $63.1M | 2.55% |
820,243
+334,000
|
|
||
11
Globus Medical
GMED
$10.9B
| $62.9M | 2.55% |
729,467
-157,533
|
|
||
12
Geron
GERN
$776M
| $61.8M | 2.5% |
41,508,659
+18,218,659
|
|
||
13
Twist Bioscience
TWST
$4.6B
| $58.3M | 2.36% |
1,226,629
-635,173
|
|
||
14
Edgewise Therapeutics
EWTX
$4.01B
| $45.7M | 1.85% |
1,449,915
+539,915
|
|
||
|
BBNX
15
Beta Bionics
BBNX
$619M
| $43.6M | 1.77% |
4,354,501
+1,819,936
|
|
||
16
Alnylam Pharmaceuticals
ALNY
$40.5B
| $43.6M | 1.76% |
131,650
+61,650
|
|
||
17
Syndax Pharmaceuticals
SNDX
$1.6B
| $40.3M | 1.63% |
1,726,908
-520,202
|
|
||
18
Indivior Pharmaceuticals
INDV
$4.43B
| $38.8M | 1.57% |
1,274,000
+1,174,000
|
|
||
19
Neuropace
NPCE
$556M
| $38.6M | 1.56% |
2,932,207
+228,999
|
|
||
20
LivaNova
LIVN
$4.05B
| $37M | 1.5% |
582,500
+15,000
|
|
||
21
Mirum Pharmaceuticals
MIRM
$5.64B
| $37M | 1.5% |
400,306
-173,308
|
|
||
|
22
BioMarin Pharmaceuticals
BMRN
$10.9B
| $36.8M | 1.49% |
650,572
-669,428
|
|
||
|
23
Progyny
PGNY
$2B
| $35.1M | 1.42% |
+2,067,000
|
|
||
24
Inspire Medical Systems
INSP
$1.22B
| $29.7M | 1.2% |
576,299
+276,900
|
|
||
|
FOCL
25
EDAP TMS S.A. American Depositary Shares
FOCL
$173M
| $27.2M | 1.1% |
7,309,254
|
|